Protara Therapeutics Inc (FRA:1KPA)
€ 1.51 -0.01 (-0.66%) Market Cap: 32.23 Mil Enterprise Value: -44.61 Mil PE Ratio: 0 PB Ratio: 0.39 GF Score: 39/100

Protara Therapeutics Inc at Cowen Health Care Conference Transcript

Mar 08, 2023 / 02:50PM GMT
Release Date Price: €3.5 (-0.57%)
Ken Cacciatore
TD Cowen - Analyst

So I want to introduce Protara, the fireside chat. Jesse, thank you for coming out and seeing us, and I'll let you introduce your team that we have with you. I think the best way to start is a little bit about your background, and take us back to how we got here.

Jesse Shefferman
Protara Therapeutics, Inc. - Co-Founder, Director, CEO

Sure.

Ken Cacciatore
TD Cowen - Analyst

How you identified the asset -- just a little bit of the history. It's always unique to hear a little bit of the background on it.

Jesse Shefferman
Protara Therapeutics, Inc. - Co-Founder, Director, CEO

Sure. So thanks, Ken. You want me to introduce the team real quick? Yeah. So I'm Jesse Shefferman, Co-Founder, CEO of Protara Therapeutics. I'm joined by my fellow Co-Founder, Chief Scientific Operations Officer, Jackie Zummo; Head of IR and Comms, Justine; and our brand new, freshly minted CFO, Pat Fabbio, who joined the company about a month ago.

So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot